Skip to main content
Top
Published in: Clinical and Experimental Nephrology 5/2015

01-10-2015 | Original Article

Longitudinal relationships of metabolic syndrome and obesity with kidney function: Healthy Twin Study

Authors: Yun-Mi Song, Joohon Sung, Kayoung Lee

Published in: Clinical and Experimental Nephrology | Issue 5/2015

Login to get access

Abstract

Background

To examine cross-sectional and longitudinal relationships, including genetic and environmental correlations, of metabolic syndrome (MetS) and obesity with kidney function.

Methods

Subjects were 3,437 Korean adults of the Healthy Twin Study for cross-sectional relationships and 1,881 participants for longitudinal relationships (follow-up interval 3.7 ± 1.4 years). Obesity (body mass index ≥ 25 vs. <25 kg/m2), MetS, and chronic kidney disease [CKD; estimated glomerular filtration rate (eGFR) (<60 mL/min/1.73 m2 using the modification of diet in renal disease study equation)] were categorized at baseline and follow-up.

Results

The prevalence and incidence of chronic kidney disease were 2.5 and 3.3 %, respectively. Compared to individuals without obesity and MetS, prevalent CKD was associated with MetS regardless of weight status [adjusted odds ratio (AOR) 4.19 for those with MetS but without obesity; AOR 4.63 for those with MetS and obesity]. Incident CKD was associated with obesity regardless of baseline metabolic status (AOR 2.03 for those with obesity but without MetS; AOR 2.85 for those with obesity and MetS). MetS at follow-up was associated with incident CKD regardless of baseline MetS (AOR 2.42–2.52). Sex-adjusted bivariate analyses show inverse environmental correlations of the number of MetS components and BMI at baseline, with eGFR at baseline and follow-up (ρ E, −0.26 to −0.42, P < 0.001).

Conclusions

MetS predicts prevalent CKD regardless of obesity, and obesity predicts incident CKD regardless of baseline MetS. Incident CKD is also associated with MetS at follow-up regardless of baseline MetS. These associations appear to be explained by shared environmental factors.
Literature
1.
go back to reference Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt K, et al. Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from kidney disease improving global outcomes. Kidney Int. 2007;72:247–59.CrossRefPubMed Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt K, et al. Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from kidney disease improving global outcomes. Kidney Int. 2007;72:247–59.CrossRefPubMed
2.
go back to reference Shin SY, Kwon MJ, Park H, Woo HY. Comparison of chronic kidney disease prevalence examined by the chronic kidney disease epidemiology collaboration equation with that by the modification of diet in renal disease equation in korean adult population. J Clin Lab Anal. 2014;28:320–7.CrossRefPubMed Shin SY, Kwon MJ, Park H, Woo HY. Comparison of chronic kidney disease prevalence examined by the chronic kidney disease epidemiology collaboration equation with that by the modification of diet in renal disease equation in korean adult population. J Clin Lab Anal. 2014;28:320–7.CrossRefPubMed
3.
go back to reference Levey AS, Stevens LA, Coresh J. Conceptual model of CKD: applications and implications. Am J Kidney Dis. 2009;53:S4–16.CrossRefPubMed Levey AS, Stevens LA, Coresh J. Conceptual model of CKD: applications and implications. Am J Kidney Dis. 2009;53:S4–16.CrossRefPubMed
4.
go back to reference Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713–35.CrossRefPubMed Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713–35.CrossRefPubMed
5.
go back to reference Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2011;6:2364–73.PubMedCentralCrossRefPubMed Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2011;6:2364–73.PubMedCentralCrossRefPubMed
6.
go back to reference Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int. 2008;73:19–33.CrossRefPubMed Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int. 2008;73:19–33.CrossRefPubMed
7.
go back to reference Tanner R, Brown T, Muntner P. Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease. Curr Hypertens Rep. 2012;14:152–9.CrossRefPubMed Tanner R, Brown T, Muntner P. Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease. Curr Hypertens Rep. 2012;14:152–9.CrossRefPubMed
8.
go back to reference Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol. 2007;2:550–62.CrossRefPubMed Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol. 2007;2:550–62.CrossRefPubMed
9.
go back to reference Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis. 2008;52:39–48.PubMedCentralCrossRefPubMed Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis. 2008;52:39–48.PubMedCentralCrossRefPubMed
10.
go back to reference MacCluer JW, Scavini M, Shah VO, Cole SA, Laston SL, Voruganti VS, et al. Heritability of measures of kidney disease among Zuni Indians: the Zuni Kidney Project. Am J Kidney Dis. 2010;56:289–302.PubMedCentralCrossRefPubMed MacCluer JW, Scavini M, Shah VO, Cole SA, Laston SL, Voruganti VS, et al. Heritability of measures of kidney disease among Zuni Indians: the Zuni Kidney Project. Am J Kidney Dis. 2010;56:289–302.PubMedCentralCrossRefPubMed
11.
go back to reference Sung J, Cho SI, Lee K, Ha M, Choi EY, Choi JS, et al. Healthy twin: a twin-family study of Korea–protocols and current status. Twin Res Hum Genet. 2006;9:844–8.CrossRefPubMed Sung J, Cho SI, Lee K, Ha M, Choi EY, Choi JS, et al. Healthy twin: a twin-family study of Korea–protocols and current status. Twin Res Hum Genet. 2006;9:844–8.CrossRefPubMed
12.
go back to reference Song YM, Lee D, Lee MK, Lee K, Lee HJ, Hong EJ, et al. Validity of the zygosity questionnaire and characteristics of zygosity-misdiagnosed twin pairs in the Healthy Twin Study of Korea. Twin Res Hum Genet. 2010;13:223–30.CrossRefPubMed Song YM, Lee D, Lee MK, Lee K, Lee HJ, Hong EJ, et al. Validity of the zygosity questionnaire and characteristics of zygosity-misdiagnosed twin pairs in the Healthy Twin Study of Korea. Twin Res Hum Genet. 2010;13:223–30.CrossRefPubMed
13.
go back to reference Levey AS, Coresh J, Balk E, Kausz AT, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–47.CrossRefPubMed Levey AS, Coresh J, Balk E, Kausz AT, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–47.CrossRefPubMed
14.
go back to reference Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract. 2007;75:72–80.CrossRefPubMed Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract. 2007;75:72–80.CrossRefPubMed
15.
go back to reference Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–52.CrossRefPubMed Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–52.CrossRefPubMed
16.
go back to reference Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–95.CrossRefPubMed Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–95.CrossRefPubMed
17.
go back to reference Comuzzie AG, Rainwater DL, Blangero J, Mahaney MC, VandeBerg JL, MacCluer JW. Shared and unique genetic effects among seven HDL phenotypes. Arterioscler Thromb Vasc Biol. 1997;17:859–64.CrossRefPubMed Comuzzie AG, Rainwater DL, Blangero J, Mahaney MC, VandeBerg JL, MacCluer JW. Shared and unique genetic effects among seven HDL phenotypes. Arterioscler Thromb Vasc Biol. 1997;17:859–64.CrossRefPubMed
18.
go back to reference Sun X, Lei SF, Deng FY, Wu S, Papacian C, Hamilton J, et al. Genetic and environmental correlations between bone geometric parameters and body compositions. Calcif Tissue Int. 2006;79:43–9.CrossRefPubMed Sun X, Lei SF, Deng FY, Wu S, Papacian C, Hamilton J, et al. Genetic and environmental correlations between bone geometric parameters and body compositions. Calcif Tissue Int. 2006;79:43–9.CrossRefPubMed
20.
go back to reference Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med. 2004;140:167–74.CrossRefPubMed Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med. 2004;140:167–74.CrossRefPubMed
21.
go back to reference Chen J, Gu D, Chen CS, Wu X, Hamm LL, Muntner P, et al. Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol Dial Transpl. 2007;22:1100–6.CrossRef Chen J, Gu D, Chen CS, Wu X, Hamm LL, Muntner P, et al. Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol Dial Transpl. 2007;22:1100–6.CrossRef
22.
go back to reference Mendy VL, Azevedo MJ, Sarpong DF, Rosas SE, Ekundayo OT, Sung JH, et al. The association between individual and combined components of metabolic syndrome and chronic kidney disease among African Americans: the Jackson Heart Study. PLoS One. 2014;9:e101610.PubMedCentralCrossRefPubMed Mendy VL, Azevedo MJ, Sarpong DF, Rosas SE, Ekundayo OT, Sung JH, et al. The association between individual and combined components of metabolic syndrome and chronic kidney disease among African Americans: the Jackson Heart Study. PLoS One. 2014;9:e101610.PubMedCentralCrossRefPubMed
23.
go back to reference Kitiyakara C, Yamwong S, Cheepudomwit S, Domrongkitchaiporn S, Unkurapinun N, Pakpeankitvatana V, et al. The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort. Kidney Int. 2007;71:693–700.CrossRefPubMed Kitiyakara C, Yamwong S, Cheepudomwit S, Domrongkitchaiporn S, Unkurapinun N, Pakpeankitvatana V, et al. The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort. Kidney Int. 2007;71:693–700.CrossRefPubMed
24.
go back to reference Locatelli F, Pozzoni P, Del Vecchio L. Renal manifestations in the metabolic syndrome. J Am Soc Nephrol. 2006;17:S81–5.CrossRefPubMed Locatelli F, Pozzoni P, Del Vecchio L. Renal manifestations in the metabolic syndrome. J Am Soc Nephrol. 2006;17:S81–5.CrossRefPubMed
25.
go back to reference Ryu S, Chang Y, Woo HY, Lee KB, Kim SG, Kim DI, et al. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes. Am J Kidney Dis. 2009;53:59–69.CrossRefPubMed Ryu S, Chang Y, Woo HY, Lee KB, Kim SG, Kim DI, et al. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes. Am J Kidney Dis. 2009;53:59–69.CrossRefPubMed
26.
go back to reference Sarafidis PA, Lasaridis AN. Insulin resistance and endothelin: another pathway for renal injury in patients with the cardiometabolic syndrome? J Cardiometab Syndr. 2008;3:183–7.CrossRefPubMed Sarafidis PA, Lasaridis AN. Insulin resistance and endothelin: another pathway for renal injury in patients with the cardiometabolic syndrome? J Cardiometab Syndr. 2008;3:183–7.CrossRefPubMed
27.
go back to reference Alpert MA, Govindarajan G, Del Rosario ML, Reisin E. The role of the renin-angiotensin system in the pathophysiology, prevention, and treatment of renal impairment in patients with the cardiometabolic syndrome or its components. J Cardiometab Syndr. 2009;4:57–62.CrossRefPubMed Alpert MA, Govindarajan G, Del Rosario ML, Reisin E. The role of the renin-angiotensin system in the pathophysiology, prevention, and treatment of renal impairment in patients with the cardiometabolic syndrome or its components. J Cardiometab Syndr. 2009;4:57–62.CrossRefPubMed
28.
go back to reference Tesauro M, Canale MP, Rodia G, Di Daniele N, Lauro D, Scuteri A, et al. Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines. Cardiol Res Pract. 2011;2011:653182.PubMedCentralPubMed Tesauro M, Canale MP, Rodia G, Di Daniele N, Lauro D, Scuteri A, et al. Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines. Cardiol Res Pract. 2011;2011:653182.PubMedCentralPubMed
29.
go back to reference Kottgen A, Pattaro C, Boger CA, Fuchsberger C, Olden M, Glazer NL, et al. New loci associated with kidney function and chronic kidney disease. Nat Genet. 2010;42:376–84.PubMedCentralCrossRefPubMed Kottgen A, Pattaro C, Boger CA, Fuchsberger C, Olden M, Glazer NL, et al. New loci associated with kidney function and chronic kidney disease. Nat Genet. 2010;42:376–84.PubMedCentralCrossRefPubMed
30.
go back to reference Chambers JC, Zhang W, Lord GM, van der Harst P, Lawlor DA, Sehmi JS, et al. Genetic loci influencing kidney function and chronic kidney disease. Nat Genet. 2010;42:373–5.PubMedCentralCrossRefPubMed Chambers JC, Zhang W, Lord GM, van der Harst P, Lawlor DA, Sehmi JS, et al. Genetic loci influencing kidney function and chronic kidney disease. Nat Genet. 2010;42:373–5.PubMedCentralCrossRefPubMed
31.
go back to reference Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Kottgen A, Levey AS, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382:158–69.CrossRefPubMed Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Kottgen A, Levey AS, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382:158–69.CrossRefPubMed
32.
go back to reference Boger CA, Heid IM. Chronic kidney disease: novel insights from genome-wide association studies. Kidney Blood Press Res. 2011;34:225–34.CrossRefPubMed Boger CA, Heid IM. Chronic kidney disease: novel insights from genome-wide association studies. Kidney Blood Press Res. 2011;34:225–34.CrossRefPubMed
Metadata
Title
Longitudinal relationships of metabolic syndrome and obesity with kidney function: Healthy Twin Study
Authors
Yun-Mi Song
Joohon Sung
Kayoung Lee
Publication date
01-10-2015
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 5/2015
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-015-1083-5

Other articles of this Issue 5/2015

Clinical and Experimental Nephrology 5/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.